Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Obesity Research & Clinical Practice|November 4, 2022
The effect of metformin on cardiovascular markers in female mice consuming a high fat dietNatasha de Alwis, Natalie K Binder, Yeukai T M Mangwiro, et al.
Ebiomedicine|February 13, 2018
Vinorelbine Potently Induces Placental Cell Death, Does Not Harm Fertility and is a Potential Treatment for Ectopic PregnancyRoxanne Hastie, Elgene Lim, Pavel Sluka, et al.
Journal of the American Heart Association|August 9, 2022
Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and PreeclampsiaRoxanne Hastie, Lina Bergman, Susan P Walker, et al.
Hypertension (Dallas, Tex. : 1979)|February 11, 2015
Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsiaKenji Onda, Stephen Tong, Anzu Nakahara, et al.
BMJ (Clinical Research Ed.)|September 23, 2021
Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trialCatherine A Cluver, Richard Hiscock, Eric H Decloedt, et al.
Placenta|August 21, 2021
Placental growth factor is negatively regulated by epidermal growth factor receptor (EGFR) signalingCarole-Anne Whigham, Roxanne Hastie, Natalie J Hannan, et al.
BMJ Open|June 18, 2024
Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trialCatherine Anne Cluver, Lina Bergman, Henrik Imberg, et al.
Hypertension (Dallas, Tex. : 1979)|September 2, 2015
Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin SecretionStephen Tong, Tu'uhevaha J Kaitu'u-Lino, Kenji Onda, et al.
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial DysfunctionKenji Onda, Stephen Tong, Sally Beard, et al.
Scientific Reports|August 17, 2021
Circulating syndecan-1 is reduced in pregnancies with poor fetal growth and its secretion regulated by matrix metalloproteinases and the mitochondriaDamanpreet Garcha, Susan P Walker, Teresa M MacDonald, et al.
Pageof 7